HEB's direction has caused me to lose sleep, and question my investing decision making,,
I am happy that today brought me some relief....more relief to come hopefully
Arrowhead is initiating coverage on Hemispherx Biopharma
Inc. with a fair value bracket of $1.67 in the low bracket and
$2.79 in the high bracket scenario using the Discounted Cash
Flow (DCF) Valuation Method.
Key Highlights: (1) Alferon N Injection® presents a huge
growth potential for the Company due to growing number of
patients in US suffering from genital warts, a common clinical
manifestation of HPV infection;(2) Further, Alferon N
Injection® is the only natural interferon approved by FDA for
marketing in the US and hence the Company enjoys a
favorable competitive position; (3) The Company is
conducting work, based on published studies, on the potential
use of natural killer cell levels and activity to act as a
biomarker for CFS, which if positive could facilitate approval
of Ampligen® for CFS.;(4) Alferon® & Ampligen® are also
good candidates for treatment of Ebola as they have
demonstrated broad anti-viral efficacy. Further, studies
indicate that nasally-delivered Ampligen® plus an intranasal
seasonal influenza vaccine induces cross-reactive antibody
formation against Avian H5N1 and H7N9 Influenza HA in
humans (5) The Company has invested more than $7.5MM to
upgrade the Alferon manufacturing facility and the
management expects this facility to be approved in
approximately one year from now; (6) The Company has
formed a strategic partnership with Armada Healthcare for
the distribution & marketing
Hemispherx Biopharma, Inc. (HEB) of the Healthcare sector (Biotechnology) has gained 2.00% per share early this morning. Hemispherx Biopharma, Inc. (HEB) traded at $0.24 with a market cap of 048, volume of 094,558 shares, a weekly performance of 5.480% and EPS growth this year of 16.70%. Hemispherx Biopharma, Inc. (HEB)’S monthly performance stands at – 2.960% and Hemispherx Biopharma, Inc. (HEB) is a stock to watch with an analyst rating of 2.00 (Scale = 5 Strong Sell – 3 Neutral – 1 Strong Buy)
News is the only thing that launch this stock to new highs,,just noise until then.
I need to quit watching this if there is no news in the morning, rarely is news released
later in the day. Check in the morning for news, and later in the day to see how it finished.
That is my "new years resolution"...twice a day, and live life!
Are you kidding me,,,shouldn't have this news sent ASTI to the moon?
Maybe I missed something here, but could there be more exciting news.?
I really hope you long-term holders are rewarded for the many years of abuse you've endured
from the naysayers who have tried to dishearten and scare you...and very excited about these drugs
that are showing some very promising hope and healing to some very sick people.
Only someone with devious motives that have something to gain by scaring weak
handed investors out of their shares so they can purchase at lower prices...
Really,,what else could it be if they were not eventually going to be buyers.
You must have better things to do than post all day long your warnings about HEB.
We got the message,, now just go away and find another stock to do your dirty business at.